NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 292 filers reported holding NOVOCURE LTD in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $740 | -78.4% | 45,780 | -44.5% | 0.00% | -100.0% |
| Q2 2023 | $3,427 | -38.4% | 82,552 | -10.8% | 0.00% | -33.3% |
| Q1 2023 | $5,563 | -2.6% | 92,522 | +18.8% | 0.00% | 0.0% |
| Q4 2022 | $5,712 | -99.9% | 77,886 | +2.6% | 0.00% | -50.0% |
| Q3 2022 | $5,767,000 | +17.4% | 75,911 | +7.4% | 0.01% | +100.0% |
| Q2 2022 | $4,911,000 | +3.1% | 70,652 | +22.9% | 0.00% | -25.0% |
| Q1 2022 | $4,765,000 | -54.4% | 57,491 | -58.7% | 0.00% | +100.0% |
| Q4 2021 | $10,442,000 | +23.2% | 139,044 | +90.6% | 0.00% | -50.0% |
| Q3 2021 | $8,475,000 | -53.5% | 72,940 | -11.3% | 0.00% | -55.6% |
| Q2 2021 | $18,235,000 | +119.0% | 82,204 | +30.5% | 0.01% | +125.0% |
| Q1 2021 | $8,327,000 | -41.8% | 63,004 | -23.8% | 0.00% | -50.0% |
| Q4 2020 | $14,304,000 | +137.5% | 82,658 | +52.8% | 0.01% | +100.0% |
| Q3 2020 | $6,023,000 | -72.4% | 54,106 | -85.3% | 0.00% | -76.5% |
| Q2 2020 | $21,805,000 | -35.5% | 367,715 | -26.7% | 0.02% | -37.0% |
| Q1 2020 | $33,795,000 | -22.9% | 501,844 | -3.6% | 0.03% | +12.5% |
| Q4 2019 | $43,854,000 | +28.4% | 520,396 | +14.0% | 0.02% | +14.3% |
| Q3 2019 | $34,150,000 | +23.7% | 456,669 | +4.6% | 0.02% | +23.5% |
| Q2 2019 | $27,600,000 | +39.6% | 436,501 | +6.3% | 0.02% | +30.8% |
| Q1 2019 | $19,774,000 | +73137.0% | 410,516 | +50895.8% | 0.01% | – |
| Q4 2018 | $27,000 | -98.2% | 805 | -97.2% | 0.00% | -100.0% |
| Q3 2018 | $1,515,000 | +457.0% | 28,895 | +231.9% | 0.00% | – |
| Q2 2018 | $272,000 | -26.7% | 8,706 | -48.8% | 0.00% | – |
| Q1 2018 | $371,000 | -26.1% | 17,013 | -31.5% | 0.00% | – |
| Q4 2017 | $502,000 | +122.1% | 24,840 | +119.3% | 0.00% | – |
| Q3 2017 | $226,000 | +135.4% | 11,328 | +104.4% | 0.00% | – |
| Q2 2017 | $96,000 | +100.0% | 5,541 | -7.4% | 0.00% | – |
| Q1 2017 | $48,000 | -90.1% | 5,983 | -90.3% | 0.00% | -100.0% |
| Q4 2016 | $484,000 | +4740.0% | 61,579 | +5105.3% | 0.00% | – |
| Q3 2016 | $10,000 | +900.0% | 1,183 | +1083.0% | 0.00% | – |
| Q2 2016 | $1,000 | -99.7% | 100 | -99.6% | 0.00% | -100.0% |
| Q1 2016 | $376,000 | +9300.0% | 26,872 | +14504.3% | 0.00% | – |
| Q4 2015 | $4,000 | – | 184 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 350,884 | $26,344,000 | 8.01% |
| HARTLINE INVESTMENT CORP/ | 318,109 | $23,884,000 | 3.27% |
| Deep Track Capital, LP | 550,000 | $41,294,000 | 2.92% |
| MORGAN JESS S & CO INC | 43,975 | $3,302,000 | 2.03% |
| Taylor Frigon Capital Management LLC | 46,376 | $3,482,000 | 1.09% |
| Darsana Capital Partners LP | 258,937 | $19,441,000 | 0.90% |
| Private Harbour Investment Management & Counsel, LLC | 13,562 | $1,018,000 | 0.81% |
| Rhenman & Partners Asset Management AB | 120,387 | $9,610,000 | 0.64% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $751,000 | 0.50% |
| Baillie Gifford | 9,615,168 | $721,906,000 | 0.40% |